Skip to content

Study of lung function, and sleep, and daytime sleepiness, and the behavior of the autonomic nervous system, and anxiety, depression, and stress in chronic renal failure patients.

Study of lung function, and maximal ventilatory pressures, and sleep, and daytime sleepiness, and nocturnal periodic legs moviments, and autonomic nervous system activity, and ansiety, and depression, and stress vulnerability, in chronic kidney disease patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7yhr4w
Enrollment
Unknown
Registered
2012-06-15
Start date
2012-04-02
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal failure, sleep apnea, psychological stress, anxiety, depression and, quality of life.

Interventions

Will be invited 57 patients to participate in this study patients with chronic renal failure from a specialized nephrology clinical setting. Patients will be consecutively clinically evaluated during
other
Z49.1

Sponsors

Universidade Nove de Julho - UNINOVE
Lead Sponsor
Universidade Nove de Julho - UNINOVE
Collaborator

Eligibility

Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients with chronic renal failure candidates to renal transplant with an indication of hemodialysis, that agree to participate in the study; Both gender; Aged between 18 and 70 years; Cognitive level sufficient for understanding the prodedures and fllowing the instructions.

Exclusion criteria

Exclusion criteria: Abuse of alcohol and or drugs;

Design outcomes

Primary

MeasureTime frame
Decrease of Apnea/hypopnea index by standard overnight polysomnography.;Increase of expiratory flow as flow drop (V'), expressed as the percentage of expiratory peak flow immediately after negative expiratory pressure application. Timepoint: This will be measured after the clinical and demographic collecting data and after obstruction diagnosis by spirometry is discarded.;Increase of periodic leg movements during sleep by the standart overnight polysomnography.;Presence of anxiety and depression checked by cutoff points greater than or equal to nine by the Hospital Anxiety and Depression scale.

Secondary

MeasureTime frame
Decrease of risk to obstructive sleep apnea through Berlin Questionnaire.;Increased stress with questionnaire Lipp Stress Symptoms Inventory for Adults.;Decrease maximal inspiratory pressure and maximal expiratory pressure evaluated by digital manuvacuometer.;Increase the sleep physiological variables, total sleep time and, sleep latency and, sleep stages and, behavior disturbes assessed by the standart overnight polysomnograph.;Increased simpathetic and decreased parassimpathetic autonomic nervous activity by heart rate variability analysis.;Decrease the neck circunference in centimeters.;Increase of quality of life assessment through the SF36 quality of life questionnaire.;Decrease diurnal excessive assessed sleepiness by the Epworth Sleepiness Scale.

Countries

Brazil

Contacts

Public ContactLuís Vicente;Luís Oliveira;Oliveira

Universidade Nove de Julho - UNINOVE;Universidade Nove de Julho - UNINOVE

oliveira.lvf@uninove.br;oliveira.lvf@pq.cnpq.br+55(11)3665-9890;+55(11)3665-9894

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Mar 22, 2026